PharmaJet links with Australia's CSL for needle-free flu vaccine delivery

USA-based PharmaJet has entered into a collaboration with Australia’s largest biotech firm CSL Limited (ASX: CSL) to enable Afluria influenza vaccine to be delivered with the PharmaJet Stratis needle-free jet injector, as soon as the 2013-2014 flu season. Adding PharmaJet jet injectors to the Afluria label will expand the delivery options for flu vaccine administration, thereby helping to broaden immunization coverage, the US firm said.

The Centers for Disease Control and Prevention (CDC) recommends an annual flu vaccination for all US citizens over 6 months old. Flu shots have proven to reduce illness, absenteeism and flu-related medical expenses. For many people, the fear of needles is enough to deter receiving a seasonal flu shot, despite the risk of contracting and spreading the illness.

CSL will seek US FDA approval for 2013-2014 flu season